Immunoglobulin isotypes in multiple myeloma: Laboratory correlates and prognostic implications in total therapy protocols

British Journal of Haematology

Volumn 145, Issue 1, 2009, Pages 134-137

  Nair, Bijay ^b   Waheed, Sarah ^b   Szymonifka, Jackie ^b   Shaughnessy Jr, John D ^b   Crowley, John ^b   Barlogie, Bart ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Immunoglobulin isotypes; Myeloma; Prognosis

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; M PROTEIN;

ARTICLE; CONCENTRATION (PARAMETERS); DISEASE COURSE; EVENT FREE SURVIVAL; GENE EXPRESSION PROFILING; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; MULTIPLE MYELOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; URINARY EXCRETION;

ANTINEOPLASTIC AGENTS; HUMANS; IMMUNOGLOBULIN ISOTYPES; MULTIPLE MYELOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 61849181011     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07547.x     Document Type: Article

References (10)

1. Barlogie, B., Jagannath, S., Desikan, K.R., Mattox, S., Vesole, D., Siegel, D., Tricot, G., Munshi, N., Fassas, A., Singhal, S., Mehta, J., Anaissie, E., Dhodapkar, D., Naucke, S., Cromer, J., Sawyer, J., Epstein, J., Spoon, D., Ayers, D., Cheson, B. Crowley, J. (1999) Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood, 93, 55 65.
2. Barlogie, B., Guido, T., Anaissie, E., Shaughnessy, J.D., Rasmussen, E., van Rhee, F., Fassas, A., Zangari, M., Hollmig, K., Pineda-Roman, M., Lee, C., Talamo, G., Thertulien, R., Kiwan, E., Krishna, S., Fox, M. Crowley, J. (2006) Thalidomide and hematopoietic-cell transplantation for multiple myeloma. New England Journal of Medicine, 354, 1021 1030.
3. Barlogie, B., Anaissie, E., van Rhee, F., Haessler, J., Hollmig, K., Pineda-Roman, M., Cottler-Fox, M., Mohiuddin, A., Alsayed, Y., Tricot, G., Bolejack, V., Zangari, M., Epstein, J., Petty, N., Steward, D., Jenkins, B., Gurley, J., Sullivan, E., Crowley, J. Shaughnessy, Jr., J. (2007) Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3. British Journal of Haematology, 138, 176 185.
4. Blade, J., Lust, J.A. Kyle, R.A. (1994) Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. Journal of Clinical Oncology, 12, 2398 2404.
5. Greipp, P., San Miguel, J., Durie, B., Crowley, J., Barlogie, B., Bladé, J., Boccadoro, M., Child, J.A., Avet-Loiseau, H., Kyle, R.A., Lahuerta, J., Ludwig, H., Morgan, G., Powles, R., Shimizu, K., Shustik, C., Sonneveld, P., Tosi, P., Turesson, I. Westin, J. (2005) International staging system for multiple myeloma. Journal of Clinical Oncology, 23, 3412 3420.
6. Krejci, M., Buchler, T., Hajek, R., Svobodnik, A., Krivanova, A., Pour, L., Adam, Z., Mayer, J. Vorlicek, J. (2005) Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients. Bone Marrow Transplantation, 35, 159 164.
7. Kyle, R., Gertz, O., Witzig, T., Lust, J., Lacy, M., Disperenzi, A., Fonseca, R., Rajkumar, S., Offord, J., Larson, D., Plevak, M., Thernaeu, T. Greipp, P. (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clinic Proceedings, 78, 21 33.
8. O'Quigley, J. Xu, R. (2001) Explained variation in proportional hazards regression, In : Handbook of Statistics in Clinical Oncology (ed by John Crowley pp. 397 409. Marcel-Dekker, New York, NY.
9. Shaughnessy, J.D., Zhan, F., Burington, B., Huang, Y., Colla, S., Hanamura, I., Stewart, J., Kordsmeier, B., Randolph, C., Williams, D., Xiao, Y., Xu, H., Epstein, J., Anaissie, E., Krishna, S., Cottler-Fox, M., Hollmig, K., Mohiuddin, A., Pineda-Roman, M., Tricot, G., van Rhee, F., Sawyer, J., Alsayed, Y., Walker, R., Zangari, M., Crowley, J. Barlogie, B. (2007) A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood, 109, 2276 2284.
10. Zhan, F., Huang, Y., Colla, S., Stewart, J.P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., Anaissie, E., Hollmig, K., Pineda-Roman, M., Tricot, G., van Rhee, F., Walker, R., Zangari, M., Crowley, J., Barlogie, B. Shaughnessy, Jr., JD. (2006) The molecular classification of multiple myeloma. Blood, 108, 2020 2028.